Fenimore Christopher R. sold REGN
February 9, 2024 · Form 4 insider transaction
Fenimore Christopher R. sold 487 shares of Regeneron Pharmaceuticals, Inc. at $951.39 per share, a transaction worth $463.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
487
Price
$951.39
Total value
$463.3K
InsiderFenimore Christopher R.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 9, 2024
Filing dateFebruary 12, 2024
Shares owned after18,460
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents volume-weighted average price of sales of 487 shares of Company stock on February 9, 2024 at prices ranging from $951.03 to $951.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.